Moe S, Rekart ML, Hernandez D, Sholpan A, Ismailov A, et al.
2023-05-01 • International Journal of Tuberculosis and Lung Disease
2023-05-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Bedaquiline (BDQ) is widely used in the treatment of rifampicin-resistant TB (RR-TB). However, resistance to BDQ is now emerging. There are no standardised regimens for ...
Nair P, Hasan T, Zaw KK, Allamuratova S, Ismailov A, et al.
2022-07-01 • International Journal of Tuberculosis and Lung Disease
2022-07-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND The WHO recommends the use of bedaquiline (BDQ) in longer, as well as shorter, multidrug-resistant TB (MDR-TB) treatment regimens. However, resistance to this new drug is ...